A classical case includes the Aurora kinase inhibitor CCT137690, which inhibits MYCN protein expression leading to chromosomal mislocalization and apoptosis, demonstrating potent anti‐tumour effects in MYCN‐AM NB cell lines as well as in primary tumour models.42 The gene discussed is MYCN; the disease is neoplasm.